美女免费一级视频在线观看
New hires:
Geron named Harout Semerjian as president and CEO, effective August 7.
Stacey Vail joined Heartbeat, a 2025 MM+M Agency 100 honoree, as chief client officer after her most recent role at Digitas Health, another 2025 MM+M Agency 100 honoree.
Medtronic named Amy Jo Meyer to succeed Torod Neptune as the company’s communications leader.
Certara hired Dr. Chris Bouton as chief technology officer.
Propel Health Communications, a 2025 MM+M Agency 100 honoree, hired Christopher Thorn as SVP, creative director and Lauren Schulz as SVP of client services.
DiaMedica announced the appointment of Julie Krop, MD as chief medical officer.
Zarminali Pediatrics announced its new chief Medical Officer, Dr. Amanda Furr.
Linda Yaccarino switched CEO roles from X to eMed, a company that develops a health management platform for GLP-1s.
MedeAnalytics named David Peterson as chief marketing officer.
Butler/Till, a 2025 MM+M Agency 100 honoree, appointed Manny Puentes as its first-ever chief product officer.
Arcinova, a Quotient Sciences company and U.K.-based contract research development and manufacturing organization, appointed Dr. Christian Dowdeswell as managing director.
Helfie.AI added to its executive team with Stefan Kulik as chief operating officer and Rania Awad as chief strategy officer.
Executive elevations:
Caty Reid was named chief growth officer at Probably Genetic.
LifeMD promoted Shayna Webb Dray to chief operating officer and elevated two other executives.
Board appointments:
Pioneering LNP Expert Dr. Pieter Cullis joined Hongene’s scientific advisory board.
Eko Health expanded its clinical advisory board with seven new appointees.
Departures:
Vertex Pharmaceuticals’ longtime chief scientific officer David Altshuler plans to retire next year
Miscellaneous:
Biogen is putting together a so-called “New Ventures” team that will invest in projects to ‘keep its early portfolio externalized.’
Richard Pazdur, the top regulator of cancer drugs at the Food and Drug Administration interceded during the late stages of a contentious review of a skin cancer therapy from Replimune Group.
Allergan Aesthetics unveiled the New Faces of Natrelle.
To view last week’s edition of The Escalator, click here.